AI Article Synopsis

  • PI(3)Ks are crucial lipid kinases that control essential cellular functions like growth and survival, and their signaling is tied to cancer development through the interaction with PKB/Akt and PTEN.
  • Genetic inactivation of the p110gamma subunit of PI(3)Kgamma in mice results in aggressive colorectal cancer.
  • In humans, loss of p110gamma is seen in colorectal tumors, but its overexpression can inhibit cancer growth in cells with mutations associated with tumor formation.

Article Abstract

Phosphoinositide-3-OH kinases (PI(3)Ks) constitute a family of evolutionarily conserved lipid kinases that regulate a vast array of fundamental cellular responses, including proliferation, transformation, differentiation and protection from apoptosis. PI(3)K-mediated activation of the cell survival kinase PKB/Akt, and negative regulation of PI(3)K signalling by the tumour suppressor PTEN (refs 3, 4) are key regulatory events in tumorigenesis. Thus, a model has arisen that PI(3)Ks promote development of cancers. Here we report that genetic inactivation of the p110gamma catalytic subunit of PI(3)Kgamma (ref. 8) leads to development of invasive colorectal adenocarcinomas in mice. In humans, p110gamma protein expression is lost in primary colorectal adenocarcinomas from patients and in colon cancer cell lines. Overexpression of wild-type or kinase-dead p110gamma in human colon cancer cells with mutations of the tumour suppressors APC and p53, or the oncogenes beta-catenin and Ki-ras, suppressed tumorigenesis. Thus, loss of p110gamma in mice leads to spontaneous, malignant epithelial tumours in the colorectum and p110gamma can block the growth of human colon cancer cells.

Download full-text PDF

Source
http://dx.doi.org/10.1038/35022585DOI Listing

Publication Analysis

Top Keywords

colon cancer
12
catalytic subunit
8
subunit pi3kgamma
8
colorectal adenocarcinomas
8
human colon
8
cancer cells
8
p110gamma
5
colorectal carcinomas
4
carcinomas mice
4
mice lacking
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!